Literature DB >> 26234521

Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics.

Alessandra M V Ritter1, Ana Paula de Faria1, Vanessa Fontana2, Rodrigo Modolo1, Heitor Moreno1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26234521      PMCID： PMC8031675          DOI： 10.1111/jch.12642

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  14 in total

1.  Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes.

Authors:  Marie Josee E van Rijn; Anna F C Schut; Yurii S Aulchenko; Jaap Deinum; Fakhredin A Sayed-Tabatabaei; Mojgan Yazdanpanah; Aaron Isaacs; Tatiana I Axenovich; Irina V Zorkoltseva; M Carola Zillikens; Huib A P Pols; Jacqueline C M Witteman; Ben A Oostra; Cornelia M van Duijn
Journal:  J Hypertens       Date:  2007-03       Impact factor: 4.844

2.  Modulation of aldosterone levels by -344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension.

Authors:  Vanessa Fontana; Ana Paula Cabral de Faria; Natália Ruggeri Barbaro; Andréa Rodrigues Sabbatini; Rodrigo Modolo; Riccardo Lacchini; Heitor Moreno
Journal:  J Am Soc Hypertens       Date:  2013-12-04

3.  High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.

Authors:  C Cuspidi; G Macca; L Sampieri; I Michev; M Salerno; V Fusi; B Severgnini; S Meani; F Magrini; A Zanchetti
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

Review 4.  Renal denervation in treatment-resistant hypertension: a reappraisal.

Authors:  Alexandre Persu; Yu Jin; Fadl Elmula M Fadl Elmula; Jean Renkin; Aud Høieggen; Sverre E Kjeldsen; Jan A Staessen
Journal:  Curr Opin Pharmacol       Date:  2015-01-17       Impact factor: 5.547

5.  Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels.

Authors:  F L Fernandes-Rosa; A C Bueno; R Molina de Souza; M de Castro; J Ernesto dos Santos; M C Foss; M-C Zennaro; H Bettiol; M A Barbieri; S R Antonini
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

6.  Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.

Authors:  Nathan D Wong; Victor A Lopez; Gilbert L'Italien; Roland Chen; Sue Ellen J Kline; Stanley S Franklin
Journal:  Arch Intern Med       Date:  2007-12-10

Review 7.  Renal sympathetic denervation for treating resistant hypertension.

Authors:  Alberto Polimeni; Antonio Curcio; Ciro Indolfi
Journal:  Circ J       Date:  2013-03-19       Impact factor: 2.993

8.  Refractory hypertension: definition, prevalence, and patient characteristics.

Authors:  Maria Czarina Acelajado; Roberto Pisoni; Tanja Dudenbostel; Louis J Dell'Italia; Falynn Cartmill; Bin Zhang; Stacey S Cofield; Suzanne Oparil; David A Calhoun
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-11-15       Impact factor: 3.738

9.  Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans.

Authors:  Margus Putku; Katrin Kepp; Elin Org; Siim Sõber; David Comas; Margus Viigimaa; Gudrun Veldre; Peeter Juhanson; Pille Hallast; Neeme Tõnisson; Sue Shaw-Hawkins; Mark J Caulfield; Elza Khusnutdinova; Viktor Kožich; Patricia B Munroe; Maris Laan
Journal:  Hum Mutat       Date:  2011-05-10       Impact factor: 4.878

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.